U-Chart Analysis:Immuno-Biological Laboratories Co., Ltd.:4570

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Immuno-Biological Laboratories Co., Ltd. Go to web site 4570 Medicals 東証グロース March 1, 2000 2007.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Immuno-Biological Laboratories Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2021年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2020年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 614 508 604 1,034 1,544
Other Current AssetsHelp 551 621 521 559 568
Tangible Fixed AssetsHelp 119 120 127 114 114
Intangible Fixed AssetHelp 0 0 0 0 -0
Investments and OthersHelp 150 455 586 666 763
Total AssetsHelp 1,434 1,705 1,838 2,373 2,988
Total Current LiabilitiesHelp 257 232 150 405 557
Total Long-term LiabilitiesHelp 99 105 59 20 286
Shareholder's EquityHelp 1,079 1,368 1,629 1,948 2,146
Total LiabilitiesHelp 1,434 1,705 1,838 2,373 2,988

Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2021年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2020年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 795 648 603 577 781
Total Sales 795 648 603 577 781
Cost of SalesHelp 268 271 256 359 321
Other Costs and RevenueHelp 816 635 666 885 628
Total CostsHelp 1,084 906 922 1,245 949
Net RevenueHelp 527 377 347 217 460
Earnings Before TaxHelp -281 -250 -311 -659 -164
Net IncomeHelp -290 -259 -319 -668 -167
Net Income -290 -259 -319 -668 -167

Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2021年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2020年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 80 -93 -194 -609 -244
Investing Cash Flow(ICF)Help 30 -156 -17 11 -593
Financing Cash FlowHelp 1 144 -216 81 -126
Exchange Difference of Cash and Cash EquivalentsHelp 2 2 5 -1 4
Net Increase and Decrease in Cash and Cash Equivalentsn 113 -103 -422 -517 -959

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Immuno-Biological Laboratories Co., Ltd.

Company where related level is highHelp

StemRIM Inc.
Nippon Shinyaku Co.,Ltd.
STELLA PHARMA CORPORATION
OncoTherapy Science,Inc.
Cyfuse Biomedical K.K.
Cuorips Inc.
Modalis Therapeutics Corporation
ECI,Inc.
MIZUHO MEDY CO.,LTD.
CanBas Co.,Ltd.